» Articles » PMID: 12239221

A CD36-initiated Signaling Cascade Mediates Inflammatory Effects of Beta-amyloid

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2002 Sep 20
PMID 12239221
Citations 166
Authors
Affiliations
Soon will be listed here.
Abstract

beta-Amyloid accumulation is associated with pathologic changes in the brain in Alzheimer's disease and has recently been identified in plaques of another chronic inflammatory disorder, atherosclerosis. The class B scavenger receptor, CD36, mediates binding of fibrillar beta-amyloid to cells of the monocyte/macrophage lineage, including brain macrophages (microglia). In this study, we demonstrate that in microglia and other tissue macrophages, beta-amyloid initiates a CD36-dependent signaling cascade involving the Src kinase family members, Lyn and Fyn, and the mitogen-activated protein kinase, p44/42. Interruption of this signaling cascade, through targeted disruption of Src kinases downstream of CD36, inhibits macrophage inflammatory responses to beta-amyloid, including reactive oxygen and chemokine production, and results in decreased recruitment of microglia to sites of amyloid deposition in vivo. The finding that engagement of CD36 by beta-amyloid initiates a Src kinase-dependent production of inflammatory mediators in cells of the macrophage lineage reveals a novel receptor-mediated pro-inflammatory signaling pathway of potential therapeutic importance.

Citing Articles

Class B Scavenger Receptor CD36 as a Potential Therapeutic Target in Inflammation Induced by Danger-Associated Molecular Patterns.

Baranova I, Bocharov A, Vishnyakova T, Chen Z, Ke Y, Birukova A Cells. 2024; 13(23).

PMID: 39682740 PMC: 11640246. DOI: 10.3390/cells13231992.


Receptors on Microglia.

Augusto-Oliveira M, Tremblay M, Verkhratsky A Adv Neurobiol. 2024; 37:83-121.

PMID: 39207688 DOI: 10.1007/978-3-031-55529-9_6.


The dualistic role of Lyn tyrosine kinase in immune cell signaling: implications for systemic lupus erythematosus.

LEstrange-Stranieri E, Gottschalk T, Wright M, Hibbs M Front Immunol. 2024; 15:1395427.

PMID: 39007135 PMC: 11239442. DOI: 10.3389/fimmu.2024.1395427.


Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer's pathology.

Gebril H, Aryasomayajula A, de Lima M, Uhrich K, Moghe P Transl Neurodegener. 2024; 13(1):2.

PMID: 38173014 PMC: 10765804. DOI: 10.1186/s40035-023-00393-7.


Role of CD36 in central nervous system diseases.

Feng M, Zhou Q, Xie H, Liu C, Zheng M, Zhang S Neural Regen Res. 2023; 19(3):512-518.

PMID: 37721278 PMC: 10581564. DOI: 10.4103/1673-5374.380821.